Showing results (451-460 of 704) with videos related to
Sort By:
Pageof 71
Dermatology Reports|December 13, 2024
The impact of COVID-19 pandemic on dermatology patients with rare skin diseasesMigena Vargu, Sabina Dedej, Ermira VasiliDermatology Reports|February 12, 2025
Lucio phenomenon: a case report on an overlooked reaction in lepromatous leprosyNatsuda Sajjachareonpong, Poonnawis Sudtikoonaseth, Kowit Kampirapap, et al.Dermatology Reports|February 6, 2025
Repair of a medial canthal defectAlberto Murtas, Virginia Maffei, Fabrizio FantiniDermatology Reports|February 6, 2025
Epidemiological and clinical profiles of cutaneous leishmaniasis cases in Amhara National Regional State, Northwest Ethiopia: a multicenter retrospective studyBizuayehu Gashaw, Endalew Yizengaw, Endalkachew Nibret, et al.Dermatology Reports|February 6, 2025
Teledermatology: Canadian dermatologists' practice patterns, perceived challenges and future recommendationsSidra Sarfaraz, Tarek Turk, Samuel A J Lowe, et al.Dermatology Reports|February 19, 2025
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experienceGioele Ghezzi, Luciano Ibba, Luigi Gargiulo, et al.Dermatology Reports|January 31, 2025
A rare vascular manifestation in chronic myeloid leukemia: a case report and literature review of Bier's spot development during nilotinib treatmentAhmed Alsaati, Turki Hakami, Sultan Bajawi, et al.Dermatology Reports|February 19, 2025
Regenerative therapies in lichen sclerosus genitalis patients and possible efficacy in preventing squamous cell carcinoma development: a long-term follow-up pilot studyMarinella Tedesco, Barbara Bellei, Lavinia Alei, et al.Dermatology Reports|February 19, 2025
A delayed Tenzel flapFrancesca Falcinelli, Giovanni Rubegni, Ernesto De PianoDermatology Reports|February 19, 2025
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugsViviana Lora, Dario Graceffa, Monia Di Prete, et al.Pageof 71